top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
STC962
Stomach cancer tissue array, set 2, non-overlapping with STC961, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$298
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Stomach carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evicence of primary tumor
Tis - Carcinoma in situ, intraepithelial tumor without invasion of the lamina propria
T1 - Tumor invades lamina pripria or submucosa
T2 - Tumor invades muscularis propria or subserosa
T3 - Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent
structures
T4 - Tumor invades adjacent structures
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Metastasis in 1 to 6 regional lymph nodes
N2 - metastasis in 7 -15 regional lymph nodes
N3 - metastasis in more than 15 regional lymph nodes
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of stomach cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 6 | Stomach | Normal | |||
A02 | M | 63 | Stomach | Normal | |||
A03 | M | 38 | Stomach | Chronic gastritis | |||
A04 | M | 67 | Stomach | Chronic gastritis | |||
A05 | M | 53 | Stomach | Chronic gastritis | |||
A06 | F | 60 | Stomach | Chronic gastritis | |||
A07 | M | 45 | Stomach | Polyps | |||
A08 | M | 38 | Stomach | Gastric ulcer | |||
A09 | M | 22 | Stomach | Gastric ulcer | |||
A10 | F | 26 | Stomach | Leiomyoma | |||
A11 | M | 58 | Stomach | Gastrointestinal stromal tumor, GIST | |||
A12 | M | 66 | Stomach | Adenocarcinoma | I | T3N1M0 | |
B01 | M | 6 | Stomach | Normal | |||
B02 | M | 63 | Stomach | Normal | |||
B03 | M | 38 | Stomach | Chronic gastritis | |||
B04 | M | 67 | Stomach | Chronic gastritis | |||
B05 | M | 53 | Stomach | Chronic gastritis | |||
B06 | F | 60 | Stomach | Chronic gastritis | |||
B07 | M | 45 | Stomach | Polyps | |||
B08 | M | 38 | Stomach | Gastric ulcer | |||
B09 | M | 22 | Stomach | Gastric ulcer | |||
B10 | F | 26 | Stomach | Leiomyoma | |||
B11 | M | 58 | Stomach | Gastrointestinal stromal tumor, GIST | |||
B12 | M | 66 | Stomach | Adenocarcinoma | I | T3N1M0 | |
C01 | M | 55 | Stomach | Adenocarcinoma | I | T3N0M0 | |
C02 | M | 52 | Stomach | Adenocarcinoma | I~II | T2N1M0 | |
C03 | M | 65 | Stomach | Adenocarcinoma | II | T3N1M0 | |
C04 | M | 63 | Stomach | Adenocarcinoma | I~II | T1N0M0 | |
C05 | M | 52 | Stomach | Adenocarcinoma | III | T3N1M0 | |
C06 | M | 70 | Stomach | Adenocarcinoma | II | T2N1M0 | |
C07 | M | 44 | Stomach | Adenocarcinoma | II | T3N0M0 | |
C08 | F | 45 | Stomach | Adenocarcinoma | II | T3N1M0 | |
C09 | M | 68 | Stomach | Adenocarcinoma | II | T3N0M0 | |
C10 | F | 72 | Stomach | Adenocarcinoma | II | T2N0M0 | |
C11 | M | 44 | Stomach | Adenocarcinoma | II | T3N2M0 | |
C12 | M | 76 | Stomach | Adenocarcinoma | II~III | T3N0M0 | |
D01 | M | 55 | Stomach | Adenocarcinoma | I | T3N0M0 | |
D02 | M | 52 | Stomach | Adenocarcinoma | I~II | T2N1M0 | |
D03 | M | 65 | Stomach | Adenocarcinoma | II | T3N1M0 | |
D04 | M | 63 | Stomach | Adenocarcinoma | I~II | T1N0M0 | |
D05 | M | 52 | Stomach | Adenocarcinoma | III | T3N1M0 | |
D06 | M | 70 | Stomach | Adenocarcinoma | II | T2N1M0 | |
D07 | M | 44 | Stomach | Adenocarcinoma | II | T3N0M0 | |
D08 | F | 45 | Stomach | Adenocarcinoma | II | T3N1M0 | |
D09 | M | 68 | Stomach | Adenocarcinoma | II | T3N0M0 | |
D10 | F | 72 | Stomach | Adenocarcinoma | II | T2N0M0 | |
D11 | M | 44 | Stomach | Adenocarcinoma | II | T3N2M0 | |
D12 | M | 76 | Stomach | Adenocarcinoma | II~III | T3N0M0 | |
E01 | M | 43 | Stomach | Adenocarcinoma | II~III | T3N1M0 | |
E02 | M | 58 | Stomach | Adenocarcinoma | III | T3N0M0 | |
E03 | F | 52 | Stomach | Adenocarcinoma | II~III | T3N1M0 | |
E04 | F | 51 | Stomach | Adenocarcinoma | II~III | T3N1M0 | |
E05 | M | 60 | Stomach | Adenocarcinoma | III | T2N1M0 | |
E06 | M | 63 | Stomach | Adenocarcinoma | III | T2N0M0 | |
E07 | M | 61 | Stomach | Adenocarcinoma | III | T3N2M0 | |
E08 | F | 71 | Stomach | Adenocarcinoma | III | T3N2M0 | |
E09 | M | 45 | Stomach | Adenocarcinoma | III | T3N2M0 | |
E10 | F | 45 | Stomach | Adenocarcinoma | III | T3N0M0 | |
E11 | F | 59 | Stomach | Adenocarcinoma | III | T3N2M0 | |
E12 | M | 62 | Stomach | Adenocarcinoma | III | T3N0M0 | |
F01 | M | 43 | Stomach | Adenocarcinoma | II~III | T3N1M0 | |
F02 | M | 58 | Stomach | Adenocarcinoma | III | T3N0M0 | |
F03 | F | 52 | Stomach | Adenocarcinoma | II~III | T3N1M0 | |
F04 | F | 51 | Stomach | Adenocarcinoma | II~III | T3N1M0 | |
F05 | M | 60 | Stomach | Adenocarcinoma | III | T2N1M0 | |
F06 | M | 63 | Stomach | Adenocarcinoma | III | T2N0M0 | |
F07 | M | 61 | Stomach | Adenocarcinoma | III | T3N2M0 | |
F08 | F | 71 | Stomach | Adenocarcinoma | III | T3N2M0 | |
F09 | M | 45 | Stomach | Adenocarcinoma | III | T3N2M0 | |
F10 | F | 45 | Stomach | Adenocarcinoma | III | T3N0M0 | |
F11 | F | 59 | Stomach | Adenocarcinoma | III | T3N2M0 | |
F12 | M | 62 | Stomach | Adenocarcinoma | III | T3N0M0 | |
G01 | M | 39 | Stomach | Adenocarcinoma | III | T2N1M0 | |
G02 | M | 65 | Stomach | Adenocarcinoma | III | T3N1M0 | |
G03 | M | 73 | Stomach | Adenocarcinoma | III | T2N1M0 | |
G04 | F | 70 | Stomach | Mucinous adenocarcinoma | T3N1M0 | ||
G05 | M | 29 | Stomach | Signet ring cell carcinoma | T3N1M0 | ||
G06 | M | 50 | Stomach | Signet ring cell carcinoma | T2N1M0 | ||
G07 | M | 59 | Stomach | Signet ring cell carcinoma | T3N0M0 | ||
G08 | M | 60 | Stomach | Adenocarcinoma | III | T2N1M0 | |
G09 | F | 53 | Stomach | Undifferentiated carcinoma | T2N0M0 | ||
G10 | M | 46 | Stomach | Undifferentiated carcinoma | T3N1M0 | ||
G11 | M | 42 | Stomach | Lymphoma, non-Hodgkin B-cell lymphoma | |||
G12 | F | 58 | Stomach | Lymphoma, MALT-B cell lymphoma, high grade | |||
H01 | M | 39 | Stomach | Adenocarcinoma | III | T2N1M0 | |
H02 | M | 65 | Stomach | Adenocarcinoma | III | T3N1M0 | |
H03 | M | 73 | Stomach | Adenocarcinoma | III | T2N1M0 | |
H04 | F | 70 | Stomach | Mucinous adenocarcinoma | T3N1M0 | ||
H05 | M | 29 | Stomach | Signet ring cell carcinoma | T3N1M0 | ||
H06 | M | 50 | Stomach | Signet ring cell carcinoma | T2N1M0 | ||
H07 | M | 59 | Stomach | Signet ring cell carcinoma | T3N0M0 | ||
H08 | M | 60 | Stomach | Adenocarcinoma | III | T2N1M0 | |
H09 | F | 53 | Stomach | Undifferentiated carcinoma | T2N0M0 | ||
H10 | M | 46 | Stomach | Undifferentiated carcinoma | T3N1M0 | ||
H11 | M | 42 | Stomach | Lymphoma, non-Hodgkin B-cell lymphoma | |||
H12 | F | 58 | Stomach | Lymphoma, MALT-B cell lymphoma, high grade | |||
null |
bottom of page